Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases

Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the... Adv Ther (2017) 34:1989–2006 DOI 10.1007/s12325-017-0582-z ORIGINAL RESEARCH Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases . . . . Sulena Shrestha Raymond Miao Li Wang Jingdong Chao Huseyin Yuce Wenhui Wei Received: April 26, 2017 / Published online: July 13, 2017 The Author(s) 2017. This article is an open access publication Medi-Cal (n = 5550) databases were matched ABSTRACT (1:1) to non-AD controls by demographic char- acteristics. AD patients were stratified by disease Introduction: Comparative data on the burden of severity (higher, lower) using treatment as a atopic dermatitis (AD) in adults relative to the gen- surrogate measure of severity. The comorbidity eral population are limited. We performed a lar- burden, HCRU, and costs were evaluated during ge-scale evaluation of the burden of disease among a 12-month follow-up period. US adults with AD relative to matched non-AD Results: In the Commercial, Medicare, and controls, encompassing comorbidities, healthcare Medi-Cal populations, patients with AD had a resource utilization (HCRU), and costs, using significantly higher overall comorbidity burden healthcare claims data. The impact of AD disease (P\0.0001), an increased risk of asthma and severity on these outcomes was also http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Therapy Springer Journals

Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases

Loading next page...
 
/lp/springer_journal/burden-of-atopic-dermatitis-in-the-united-states-analysis-of-QPvY60T0ij
Publisher
Springer Healthcare
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Oncology; Cardiology; Rheumatology; Endocrinology; Pharmacology/Toxicology
ISSN
0741-238X
eISSN
1865-8652
D.O.I.
10.1007/s12325-017-0582-z
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial